Nunatak Biotech
PrivateLast Round
Accelerator
Jun 19, 2025
Total Funding Raised
$107,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nunatak Biotech is a biotechnology company that develops nature-based solutions to address challenges such as climate change, soil degradation, and food security. The company utilizes a proprietary biotechnology platform that integrates data on soils, plants, fungi, and bacteria to design effective plant-microorganism associations. Its products are derived from extremophiles—microorganisms sourced from extreme environments like Antarctica—which help crops like wheat and barley build resilience against environmental stressors, including saline soils and drought. The founding team leverages over 20 years of experience in scientific research in Antarctica. Nunatak Biotech partners with the agricultural industry to improve crop yields and soil health, aiming to promote sustainable growth.
Sector
Energy & Sustainability
Verticals
Biotechnology, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nunatak Biotech Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Nunatak Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 19, 2025 |
Key People
Founding team and executive leadership
Nunatak Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SVG Ventures|THRIVE | Accelerator |
| Eatable Adventures | Accelerator |
| German Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 35% MoM.
- Apr 17, 2026
Monthly visitors grew 192% MoM from 150 to 438.
Nunatak Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nunatak Biotech's valuation, stock price, and market status.